Global Acne Treatment Market By Type (Mild, Moderate, Moderate To Severe), By Treatment (Therapeutic Treatment, Devices), By Drug Type (OTC, Prescription), By Route Of Administration (Topical, Oral, and Injectable By End User (Hospitals & Clinics, Specialty Clinics, Retail Stores and Other Users), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032 

Report Overview

The Global acne treatment market size is expected to be worth around USD 16.2 Bn by 2032 from USD 9.7 Bn in 2022, growing at a CAGR of 5.4% during the forecast period from 2022 to 2032.

The Acne Treatment Market is expanding rapidly, with new products and treatments constantly being developed. Acne can affect individuals of any age group, but it is more common in young people and teenagers. Therefore, companies are competing for a piece of the lucrative acne market.

Market Scope

Type Analysis

The Moderate Acne Segment Held The Largest Share And Is Anticipated To Be The Fastest Market.

Based on type, the market for acne treatment has been segmented into mild, moderate, and moderate to severe. Among these types, the moderate segment is the most lucrative due to increased concern over facial skincare and the rising prevalence of acne. There are more severe cases of whiteheads and blackheads than mild ones, characterized by more papules. Severe acne refers to severe cases with large, painful, cyst-like papules, pustules, nodules, or cysts.

Treatment Analysis

Therapeutic Treatment Holds The Largest Market Share

Acne medications are used for the treatment of bacterial infection and to reduce oil production or swelling. Due to the recent approval of newer acne medications, this market is expanding. Cassiopea SpA, based in Italy, received FDA approval for its acne treatment Winlevi (1% clascoterone cream) in August 2020. Similarly, tazarotene’s new drug application (ARAZLO), created by Bausch Health Companies Inc., and approved by the US FDA in December 2019, is meant to treat acne vulgaris. Based on the treatment of therapeutic devices, the acne treatment market is segmented into microdermabrasion and laser treatment. The growth of this market is due to technological advancements in acne treatment. Laser treatment aims at minimizing the appearance of scars from previous acne outbreaks. The treatment therapy uses continuous light to treat scar tissue and helps in the growth of healthy skin cells.

Drug Analysis

The OTC Segment Accounted For A Larger Market Share Owing To Frequent Purchases, Mostly By The Population With Mild Acne.

Many over-the-counter (OTC) acne treatments contain salicylic acid and benzoyl peroxide. These medications come in oral, topical, and injectable forms. OTC medications are most commonly used by mildly-affected people. OTC medicines are in high demand due to mild acne. This will likely help the market grow at an impressive rate over the forecast period. Topical treatment for acne includes antibiotics and isotretinoin. This segment has experienced significant development with the approvals of therapeutic devices and drugs.

By Route Of Administration

The Market Will Be Dominated By The Topical Category For The Entire Forecast Period. The Reason For This Is The Increasing Demand For Topical Treatments Due To The Ease Of Access And Comfort They Offer.

During the forecast period, the topical segment is anticipated to dominate the market. Due to the growing number of companies producing topical solutions for acne treatment, the topical segment is expected to dominate the market during the forecast period. This is because patients are primarily captivated by topical solutions because they are readily available and comfortable.

End-User Analysis

The Growth Of The Acne Treatment Market In The Hospital And Clinics Segment Is Driven By The Increasing Prevalence Of Skin Disorders, Including Acne

According to the American Academy of Dermatology Association, acne affects nearly 85% of teenagers at some point in their adolescence. Over 50 million people in the US suffer from acne in total. Acne treatment clinics and hospitals are ultimately involved in all of these cases. This segment is driven by the presence of dermatologist specialists and advanced technology. The segment is also being driven by the growing demand for specialty care and rising spending on skincare

Key Market Segments

By Type

• Mild
• Moderate
• Moderate to Severe

By Treatment

• Therapeutic Treatment
• Devices

By Drug Type

• OTC
• Prescription

By Route of Administration

• Topical
• Oral
• Injectable

By End-Users

• Hospitals & Clinics
• Specialty Clinics
• Retail Stores
• Other Users

Market Dynamics

Drivers

The Unhealthy Lifestyle Which Is Followed By The People Helps To Boost The Market For Acne Treatment

Acne occurs when the skin secretes too much oil. This causes the pores to clog and eventually leads to a more severe eruption. People are more stressed due to modernization and increased urbanization. A stressful lifestyle can negatively impact the hormone balance and the secretion process. This can have a direct effect on the amount of oil secreted by your skin, which can lead to a minor breakout known as acne. International companies have flexible work schedules, which can negatively impact people’s lifestyles. Bad lifestyles can have a direct effect on the texture and quality of your skin. Globally, skin disorders are increasing in prevalence.

The number of people opting for this treatment is rapidly increasing in both established and emerging countries. Global awareness of available acne treatment options is increasing due to the availability of many acne medications such as isotretinoin and retinoid. Market expansion is expected to be driven by increasing patients’ awareness.

Reduced Costs For Acne Treatments And Rising Demand For Hormonal Therapy Are Two Key Factors Driving The Market’s Revenue Growth

Most topical treatments do not work for cystic acne. Oral medications can be used to balance hormones and clear the skin. The anti-androgen medication works by decreasing the levels of androgen in men. Hormones are naturally produced in large quantities by both men and women. An excess of androgen can cause acne by interfering with hair follicles, which control the production and oil production. Treatment-resistant acne can be treated with hormonal therapies for patients who are not hyper androgenic but also those who have biochemical or cutaneous signs. This will likely lead to a rapid rise in demand for hormonal therapy.

Restraints

Adoption Is Being Hampered By Side Effects Associated With Currently Available Drugs

Despite the prevalence of acne worldwide, there are some obstacles that prevent the industry from growing. One of these is the adverse effects of acne medication. According to the National Center for Biotechnology Information, (NCBI), nausea, vomiting, and diarrhea are the most common side effects of antibiotics in approximately 7% of tetracycline users and 4% of macrolide patients. The Food and Drug Administration (FDA), United States, has warned against using some OTC drugs that could cause severe irritation or potentially fatal allergic reactions.

The Products Safety Concerns

The severity of side effects from acne treatments depends on how the treatment is performed and the strength of the medicine. Skin irritation and dryness are the most common side effects of topical medications for acne. Oral drugs may cause more severe side effects. Antibiotics can cause stomach upsets or dizziness in patients. Oral isotretinoin can also cause severe side effects, especially if the woman is pregnant. Infants born to mothers taking isotretinoin during pregnancy have severe congenital disabilities. It can increase the risk of depression and suicidal thoughts and impact liver function and cholesterol levels. Safety concerns regarding acne treatment products will slow the market development.

Opportunity

Rising Awareness About Current And New Acne Treatment

The demand for non-invasive cosmetic treatments is increasing worldwide. Most dermatologists treat skin problems using topical or less invasive procedures than surgical ones. In addition, increasing pollution levels may lead to severe skin concerns, which cause acne and rashes on the skin. Owing to this, individuals seek advanced treatments that can help with skin issues. Moreover, the growing skincare awareness creates lucrative opportunities for emerging key players.

Trends

Growing Clinical Approval Of Drugs To Drive Market Growth

Manufacturers have noticed a rise in the prevalence of this condition among adolescents and adults, which has boosted the demand for medication. The challenge of treating acne safely and effectively is the focus of drug development. The U.S. Food and Drug Administration (FDA) has approved the new abbreviated application for topical dermatology adapalene gel USP 0.3% manufactured by Alembic Pharmaceuticals to treat acne vulgaris.

COVID-19 Analysis

Loss Of Revenue In Drug Usage Experienced Due To Decline In-Patient Visits During COVID-19 Pandemic

Due to the decreased number of people seeking treatment worldwide, the ongoing pandemic slowed the growth of acne drugs. Due to COVID-19, the market’s dominant players suffered severe revenue losses. In particular, the lockdown period showed decreased production, redistribution, and disruption of supply chains as well as other factors that affected drug sales, particularly in 2020. The American Association of Dermatology conducted a study with dermatologists in the United States and found that there was a 43% drop in weekly consultations for patients during the lockdown period. This is almost four times the level of the pre-COVID-19 levels.

Regional Analysis

North America Region Accounted Significant Share Of The Global Acne Market

North America will have the largest share of the acne treatment market during the projected years due to its growing population and increasing beauty-related problems. The market will grow further by launching new products by regional players and increase in the count of patients. Europe will also witness a significant market share due to its growing patient base and increased investment in research and treatment of dermatology issues. Market share will rise due to the increasing use of cutting-edge solutions and treatments.

Key Regions

• North America
  • The US
  • Canada
  • Mexico

• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe

• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe

• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC

• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America

• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

Focus On Inorganic Growth Strategies Propelled Allergan Plc And Botanix Pharmaceuticals To Lead Global Market

The company’s substantial investment in research to create a superior portfolio of treatment options has helped it become a market leader. There are many significant players in the market offering different types of drugs. These companies will be able to generate strong revenues and offer a wide range of drugs. Allergan plc, Galderma Laboratories, and Bausch Health companies are strong contributors to key growth areas. In April 2021, Bausch Health Companies Inc. reported significant topline results from Phase 3 trials of IDP-126 Gel to treat Acne Vulgaris. Companies of smaller sizes, which have limited product offerings, are also part of the competitive landscape. Smaller companies with a strong local presence, like Botanix Pharmaceuticals or Valeant Pharmaceutical International, Inc., will likely expand during the forecast period.

Recent Development

In January 2022: Galderma Laboratories) has disclosed the approval it was granted by the United States authorities. It had completed ALASTIN Skincare’s charges regarding the development of clinically-tested products approved by doctors.

In March 2022: Galderma Laboratories launched TWYNEO Cream in America to treat facial acne during the American Academy of Dermatology Annual Conference. It is now commercially available in spring.

Market Key Players

With several local and regional players, the market for companion diagnostics is fragmented. Market players are subject to intense competition from top market players, particularly those with strong brand recognition and high distribution networks. As a result, companies have gained various expansion strategies, such as partnerships and product launches, to stay on top of the market.

The following are some of the major players in the Global Acne Treatment industry:

• GlaxoSmithKline plc.
• Almirall, S.A.
• Galderma Laboratories
• Hoffman La Roche Ltd
• Bausch Health Companies Inc
• Leo Pharma A/S
• Johnson & Johnson Services Inc
• Teva Pharmaceutical Industries Ltd
• Candela Corporation
• Vyne Therapeutics Inc.
• Other Key Players

Report Scope